Quality of life assessment in patients of psoriasis


  • Saima Rahman
  • Shahbaz Aman
  • Dr. Nisaruddin
  • Muhammad Nadeem
  • Atif Hasnain Kazmi


Quality of life, DLQI, psoriasis, PASI


Objective To determine the impact of psoriasis on quality of life (QoL) using Dermatology Life Quality Index (DLQI) in patients of psoriasis presenting in a tertiary care setting. Methods An observational study was carried out at Department of Dermatology, King Edward Medical University/ Mayo Hospital, Lahore from May 2013 till November 2013. A total of 200 patients compatible with inclusion criteria were enrolled after taking informed consent and were asked to fill DLQI questionnaires. Results Out of 200 patients, there were 107 males and 93 females. The mean age was 34.89±14.96 years while the mean DLQI score was 11.51±4.81. There were 58 (29%) married and 142 (71%) unmarried patients in the present study. Patients with moderate psoriasis were 184 with PASI score 40-60 and mean DLQI score 11.14±4.55 whereas 16 patients had severe psoriasis with PASI score 60-72 and mean DLQI score 15.8±5.68. The maximum mean DLQI score was highest for question 10 (treatment) followed by question 1 and 2 (symptoms and feelings). Conclusion Psoriasis is a serious condition and is associated with significantly lower quality of life regardless of age, gender, duration and severity of disease or marital status.  


Finlay AY, Smith CH. General Aspects of Treatment. Rook's Textbook of Dermatology: Wiley-Blackwell; 2010. p. 1-34.

Burns T, Breathnach S, Cox N, Griffiths C. Rook's Textbook of Dermatology, 4 Volume Set: John Wiley & Sons; 2010.

National psoriasis foundation. About psoriasis: statistics.

Heller MM, Wong JW, Nguyen TV, Lee ES, Bhutani T, Menter A, et al. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatologic clinics. 2012;30(2):281-91.

Manjula V, Sreekiran S, Saril PS, Sreekanth M. A study of psoriasis and quality of life in a tertiary care teaching hospital of Kottayam, Kerala. Indian journal of dermatology. 2011;56(4):403.

Rakhesh S, D'Souza M, Sahai A. Quality of life in psoriasis: a study from south India. Indian Journal of Dermatology, Venereology, and Leprology. 2008;74(6):600.

Schöffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, et al. Costs and quality of life in patients with moderate to severe plaque‐type psoriasis in Germany: A multi‐center study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2007;5(3):209-18.

Kanikowska A, Kramer L, Pawlaczyk M. Quality of life in Polish patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. 2009;23(1):92-3.

Mork C, Wahl A, Moum T. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics. ACTA DERMATOVENEREOLOGICA-STOCKHOLM-. 2002;82(5):347-51.

Farber E, Nall L. Epidemiology: natural history and genetics. BASIC AND CLINICAL DERMATOLOGY. 1998;16:107-58.

Yip SY. The prevalence of psoriasis in the Mongoloid race. Journal of the American Academy of Dermatology. 1984;10(6):965-8.

Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Kremers HM. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. Journal of the American Academy of Dermatology. 2009;60(3):394-401.

Kavli G, Førde OH, Arnesen E, Stenvold SE. Psoriasis: familial predisposition and environmental factors. Br Med J (Clin Res Ed). 1985;291(6501):999-1000.

Convit J, editor Investigation of the incidence of psoriasis among Latin American Indians. Proceedings of the 13th Congress on Dermatology Amsterdam; 1962.

Lomholt G. Psoriasis: prevalence, spontaneous course and genetics. A census study on the prevalence of skin diseases on the Faroe Islands: Føroya fróðskaparfelag; 1963.

Brathen L, Botten G, Bjerkedal T. Prevalence of psoriasis in Norway. Acta Derm Venereol. 1989;142:5-8.

Bell LM, Sedlack R, Beard CM, Perry HO, Michet CJ, Kurland LT. Incidence of psoriasis in Rochester, Minn, 1980-1983. Archives of dermatology. 1991;127(8):1184-7.

Burge S, Matin R, Wallis D. Oxford handbook of medical dermatology: Oxford University Press; 2016.

Lee YW, Park EJ, Kwon IH, Kim KH, Kim KJ. Impact of psoriasis on quality of life: relationship between clinical response to therapy and change in health-related quality of life. Annals of dermatology. 2010;22(4):389-96.

Pal SS, Haroon TS, K K. Measurement of Quality of Life in patients with Psoriasis. Pak Postgrad Med J. 1998;9(92-4).

Fry L. The Encyclopedia of Visual Medicine Series: An Atlas of Dermatology. New York: The Parthenon Publishing Group; 1997.

Maziar A, Farsi N, Mandegarfard M, Babakoohi S, Gorouhi F, Dowlati Y, et al. Unwanted facial hair removal with laser treatment improves quality of life of patients. Journal of Cosmetic and Laser Therapy. 2010;12(1):7-9.

Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean?. Journal of Investigative Dermatology. 2005 Oct 31;125(4):659-64.




How to Cite

Rahman S, Aman S, Nisaruddin D, Nadeem M, Kazmi AH. Quality of life assessment in patients of psoriasis. J Pak Assoc Dermatol [Internet]. 2018Dec.13 [cited 2024Jun.24];28(2):186-92. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1154



Original Articles

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>